Biotech
-
236PharmaCyte Biotech Climbing Back Up The Charts
Shares of PharmaCyte Biotech are climbing back up the charts after being on a downtrend for the past year. The stock hit highs of...
-
280Compass Pathways Investors Need To Look At MMEDF
Compass Pathways is a new IPO that shot up the NASDAQ charts over the past week. Investors are jumping on the stock because...
-
4611RLFTF Is Tremendously Undervalued
RLFTF remains one of our favorite COVID-19 plays here at Insider Financial. In our last profile of the company, we focused on...
-
480RVVTF Is A Cheap COVID-19 Play
Let’s face it, COVID-19 isn’t going away anytime soon. While we have nailed many Big Board COVID-19 plays like Moderna, Inovio Pharmace...
-
15.9KNWBO Stock Has Enormous Potential
NWBO stock has been depressed for a number of years after suffering a relentless short and distort campaign led by the so-called “Night...
-
285Sorrento Stock: The Mayo Clinic News Is A Big Deal
Anyone that has followed us for quite some time knows that we have been bullish on Sorrento stock since the COVID-19 pandemic started....
-
7.3KIs Jaguar Health Stock Heading To $1?
Here at Insider Financial, we specialize in finding momentum BEFORE it happens. We look for bottoming patterns, breakouts, and catalysts that are...
-
12.6KInovio Stock: Ignore Muddy Waters Research
Carson Block and Muddy Waters Research are out with another hit piece. This time it’s on Inovio stock. MW is short $INO. Stock...
-
3422iBio Inc Gearing Up For A Major Move
There was a lot of profit-taking and selling in many COVID-19 plays in August. Some names did get ahead of themselves and...
-
7.1KOpko Stock: Why You Should Buy The Dip
We last profiled Opko stock earlier this summer before the run to $6, which you can read here. However, in the past...